PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 6 51-6, 2005, Pages

  Schadinger, Susan E ^a   Bucher, Nancy L R ^a   Schreiber, Barbara M ^a   Farmer, Stephen R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose differentiation related protein; Lipid droplets; Nonalcoholic fatty liver disease; Peroxisome proliferator activated receptor 2; Steatosis; Triacylglycerol

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPOCYTE FATTY ACID BINDING PROTEIN 4; ADIPONECTIN; ADIPOPHILIN; ALBUMIN; ALPHA 1 ANTITRYPSIN; DEXAMETHASONE; FAT DROPLET; FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPATOCYTE NUCLEAR FACTOR 4; INSULIN; ISOBUTYLMETHYLXANTHINE; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; PROTEIN AP2; SELENIUM; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSFERRIN; TRIACYLGLYCEROL; TROGLITAZONE; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ADFP PROTEIN, MOUSE; ANTIDIABETIC AGENT; AZO COMPOUND; CARRIER PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CHROMAN DERIVATIVE; DNA BINDING PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; OIL RED O; SREBF1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FATTY LIVER; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIPID STORAGE; LIPOGENESIS; LIVER CELL; LIVER CELL CULTURE; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEATOSIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMISTRY; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; LIPID METABOLISM; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ACETYL-COA CARBOXYLASE; ANIMALS; AZO COMPOUNDS; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEINS; CHROMANS; DNA-BINDING PROTEINS; FATTY ACID SYNTHETASE COMPLEX; FATTY ACID-BINDING PROTEINS; FATTY LIVER; GENE EXPRESSION; HEPATOCYTES; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, OBESE; MICROSCOPY, CONFOCAL; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 19444383246     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00513.2004     Document Type: Article

References (57)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
2. Angulo P, Keach JC, Batts KP, and Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362, 1999.
3. Angulo P and Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17, Suppl: S186-S190, 2002.
4. Arimura N, Horiba T, Imagawa M, Shimizu M, and Sato R. The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes. J Biol Chem 279: 10070-10076, 2004.
5. Bartels ED, Lauritsen M, and Nielsen LB. Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes 51: 1233-1239, 2002.
6. Bedoucha M, Atzpodien E, and Boelsterli UA. Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J Hepatol 35: 17-23, 2001.
7. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, and Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132: 112-117, 2000.
8. Bennett MK, Lopez JM, Sanchez HB, and Osborne TF. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J Biol Chem 270: 25578-25583, 1995.
9. Berg AH, Combs TP, Du X, Brownlee M, and Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953, 2001.
10. Brasaemle DL, Barber T, Kimmel AR, and Londos C. Post-translational regulation of perilipin expression. Stabilization by stored intracellular neutral lipids. J Biol Chem 272: 9378-9387, 1997.
11. Brasaemle DL, Barber T, Wolins NE, Serrero G, Blanchette-Mackie EJ, and Londos C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J Lipid Res 38: 2249-2263, 1997.
12. Brown MS and Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340, 1997.
13. Brown MS and Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96: 11041-11048, 1999.
14. Burant CF, Sreenan S, Hirano K, Tai TA, Lohmiller J, Lukens J, Davidson NO, Ross S, and Graves RA. Troglitazone action is independent of adipose tissue. J Clin Invest 100: 2900-2908, 1997.
15. Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O, and Reitman ML. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106: 1221-1228, 2000.
16. Dennis JE and Charbord P. Origin and differentiation of human and murine stroma. Stem Cells 20: 205-214, 2002.
17. Dubuquoy L, Dharancy S, Nutten S, Pettersson S, Auwerx J, and Desreumaux P. Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360: 1410-1418, 2002.
18. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, and Auwerx J. The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 272: 18779-18789, 1997.
19. Gao J, Ye H, and Serrero G. Stimulation of adipose differentiation related protein (ADRP) expression in adipocyte precursors by long-chain fatty acids. J Cell Physiol 182: 297-302, 2000.
20. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, and Reitman ML. Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278: 34268-34276, 2003.
21. Greenberg AS, Egan JJ, Wek SA, Garty NB, Blanchette-Mackie EJ, and Londos C. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 266: 11341-11346, 1991.
22. Greenberg AS, Egan JJ, Wek SA, Moos MC Jr, Londos C, and Kimmel AR. Isolation of cDNAs for perilipins A and B: sequence and expression of lipid droplet-associated proteins of adipocytes. Proc Natl Acad Sci USA 90: 12035-12039, 1993.
23. Gustafson B, Jack MM, Cushman SW, and Smith U. Adiponectin gene activation by thiazolidinediones requires PPARγ2, but not C/EBPα-evidence for differential regulation of the aP2 and adiponectin genes. Biochem Biophys Res Commun 308: 933-939, 2003.
24. Hamm JK, Park BH, and Farmer SR. A role for C/EBPβ in regulating peroxisome proliferator-activated receptor γ activity during adipogenesis in 3T3-L1 preadipocytes. J Biol Chem 276: 18464-18471, 2001.
25. Han J, Farmer SR, Kirkland JL, Corkey BE, Yoon R, Pirtskhalava T, Ido Y, and Guo W. Octanoate attenuates adipogenesis in 3T3-L1 preadipocytes. J Nutr 132: 904-910, 2002.
26. Hayhurst GP, Lee YH, Lambert G, Ward JM, and Gonzalez FJ. Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21: 1393-1403, 2001.
27. Kim JB, Wright HM, Wright M, and Spiegelman BM. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc Natl Acad Sci USA 95: 4333-4337, 1998.
28. Londos C, Brasaemle DL, Schultz CJ, Segrest JP, and Kimmel AR. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol 10: 51-58, 1999.
29. Magana MM and Osborne TF. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. J Biol Chem 271: 32689-32694, 1996.
30. Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B Jr, Reitman ML, and Gonzalez FJ. Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111: 737-747, 2003.
31. Nagai S, Shimizu C, Umetsu M, Taniguchi S, Endo M, Miyoshi H, Yoshioka N, Kubo M, and Koike T. Identification of a functional peroxisome proliferator-activated receptor responsive element within the murine perilipin gene. Endocrinology 145: 2346-2356, 2004.
32. Rahimian R, Masih-Khan E, Lo M, van Breemen C, McManus BM, and Dube GP. Hepatic overexpression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem 224: 29-37, 2001.
33. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, and Spiegelman BM. C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev 16: 22-26, 2002.
34. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, and Mortensen RM. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4: 611-617, 1999.
35. Schreiber BM, Martin BM, Hollander W, and Franzblau C. β-VLDL-induced alterations in growth potentiating activity produced by mononuclear phagocytes. Atherosclerosis 69: 69-79, 1988.
36. Schreiber BM, Veverbrants M, Fine RE, Blusztajn JK, Salmona M, Patel A, and Sipe JD. Apolipoprotein serum amyloid A downregulates smooth-muscle cell lipid biosynthesis. Biochem J 344: 7-13, 1999.
37. Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, and Shimano H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38: 1529-1539, 2003.
38. Servetnick DA, Brasaemle DL, Gruia-Gray J, Kimmel AR, Wolff J, and Londos C. Perilipins are associated with cholesteryl ester droplets in steroidogenic adrenal cortical and Leydig cells. J Biol Chem 270: 16970-16973, 1995.
39. Shimomura I, Bashmakov Y, Shimano H, Horton JD, Goldstein JL, and Brown MS. Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. Proc Natl Acad Sci USA 94: 12354-12359, 1997.
40. Souza SC, Muliro KV, Liscum L, Lien P, Yamamoto MT, Schaffer JE, Dallal GE, Wang X, Kraemer FB, Obin M, and Greenberg AS. Modulation of hormone-sensitive lipase and protein kinase A-mediated lipolysis by perilipin A in an adenoviral reconstituted system. J Biol Chem 277: 8267-8272, 2002.
41. Student AK, Hsu RY, and Lane MD. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 255: 4745-4750, 1980.
42. Tansey JT, Huml AM, Vogt R, Davis KE, Jones JM, Fraser KA, Brasaemle DL, Kimmel AR, and Londos C. Functional studies on native and mutated forms of perilipins. A role in protein kinase A-mediated lipolysis of triacylglycerols. J Biol Chem 278: 8401-8406, 2003.
43. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, Reitman ML, Deng CX, Li C, Kimmel AR, and Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 98: 6494-6499, 2001.
44. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, Tempst P, and Spiegelman BM. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR γ and RXR α. Nucleic Acids Res 22: 5628-5634, 1994.
45. Tontonoz P, Hu E, Graves RA, Budavari AI, and Spiegelman BM. mPPAR γ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8: 1224-1234, 1994.
46. Unger RH. Lipotoxic diseases. Annu Rev Med 53: 319-336, 2002.
47. Unger RH and Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 15: 312-321, 2001.
48. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF, and Flier JS. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99: 2416-2422, 1997.
49. Wu JC, Merlino G, and Fausto N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor α. Proc Natl Acad Sci USA 91: 674-678, 1994.
50. Wu Z, Bucher NL, and Farmer SR. Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPΔ, and glucocorticoids. Mol Cell Biol 16: 4128-4136, 1996.
51. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, and Spiegelman BM. Cross-regulation of C/EBP α and PPAR γ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3: 151-158, 1999.
52. Wu Z, Xie Y, Morrison RF, Bucher NL, and Farmer SR. PPARγ induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPα during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest 101: 22-32, 1998.
53. Xu J, Teran-Garcia M, Park JH, Nakamura MT, and Clarke SD. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J Biol Chem 276: 9800-9807, 2001.
54. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Kara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, and Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946, 2001.
55. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, and Reddy JK. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression. J Biol Chem 278: 498-505, 2003.
56. Zaret KS. Hepatocyte differentiation: from the endoderm and beyond. Curr Opin Genet Dev 11: 568-574, 2001.
57. Zaret KS. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet 3: 499-512, 2002.